Latest News about GSK
Recent news which mentions GSK
From Benzinga
GSK To Scoop Clinical Stage US Biotech Affinivax For $3.3B To Shore Up Vaccine Business
May 31, 2022
From Benzinga
From Benzinga
Tickers
GSK
From MarketWatch
Biotech stocks get a boost, or plunge, as new clinical data is shared before major cancer meeting
May 27, 2022
From MarketWatch
From Motley Fool
How to find the best stocks in a bad market using legendary investor Geraldine Weiss’s proven strategy
May 13, 2022
From MarketWatch
HC Wainwright Says This Stock Is Well Capitalized For Value Realization Of Pipeline, Despite COVID-19 Uncertainty
May 12, 2022
From Benzinga
Why GSK May Have Bet Too Big on a Pandemic Pipeline
May 07, 2022
From Motley Fool
GlaxoSmithKline Clocks 32% Topline Growth Buoyed By COVID-19 Therapy, Shingrix Vaccine
April 27, 2022
Tickers
GSK
From Benzinga
From Benzinga
From MarketWatch
Public-health Authorities in US, UK, Probe Mysterious Cases Of Severe Hepatitis In Young Kids: WSJ
April 22, 2022
From Benzinga
From Benzinga
From Benzinga
4 Undervalued Biotech Stocks to Add to Your Buy List
April 20, 2022
From InvestorPlace
As Evolving Pandemic Response, Officials Shift To Personal Choice On COVID-19 Boosters, Masks: WSJ
April 18, 2022
From Benzinga
The Week Ahead In Biotech (April 17-April 23): J&J, Abbott Earnings, Adcom Test For TG Therapeutics And More
April 17, 2022
From Benzinga
From Motley Fool
2 Unstoppable Green Flags for AbbVie
April 14, 2022
From Motley Fool
Why Is Sierra Oncology (SRRA) Stock Up Today?
April 13, 2022
From InvestorPlace
Sierra Oncology Stock Is Soaring: Here's Why
April 13, 2022
From Benzinga
From Benzinga
Why Sierra Oncology Stock Is Soaring Today
April 13, 2022
From Motley Fool
From Benzinga
From InvestorPlace
GlaxoSmithKline to buy Sierra Oncology for $1.9 billion
April 13, 2022
From MarketWatch
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.